Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CStone Pharmaceuticals Co. Ltd.

http://www.cstonepharma.com

Latest From CStone Pharmaceuticals Co. Ltd.

Shanghai Reopens, Beijing Offers Policy Relief As Pharma Embraces Uncertain Future

China’s largest commercial center and pharma industry hub reopens after over two months of strict lockdown.

Coronavirus COVID-19 China

Younger Females' Cancer Incidence Increases Significantly In China

Latest data show a worrying public health trend that remains the top health concern in China despite surging COVID infections.

China Cancer

Finance Watch: Financial Market Turmoil Ends Amicus SPAC Deal For Gene Therapy Spinout

Public Company Edition: As their stock prices plummet, Adagio reshuffles its research plan and names a new CEO, while Yumanity restructures and seeks strategic alternatives. Also, Bristol sells $6bn worth of notes, Amgen issues $750m green bond, and Inhibrx and Amryt amend and refinance debt.

Financing Business Strategies

Lilly/Innovent Experience Show Hurdles Remaining For Chinese PD-1 Inhibitors

China has fielded several homegrown checkpoint inhibitors, using lower cost as an argument for the US market, but sintilimab – a key test case – has underscored FDA skepticism.

Cancer ImmunoOncology
See All

Company Information

UsernamePublicRestriction

Register